While glucose uptake efficacy was used as an initial experimental validation of our predicted peptides, the ultimate objective of the predictor was to identify peptides capable of stimulating GLUT4 translocation to the plasma membrane, which is known to be decreased in type 2 diabetics [46]. Here, SLC2A4 is linked to type 2 diabetes mellitus.